Literature DB >> 31679041

Melatonin supplementation and pro-inflammatory mediators: a systematic review and meta-analysis of clinical trials.

Meysam Zarezadeh1, Masoud Khorshidi2,3, Mohammadreza Emami4, Parisa Janmohammadi4, Hamed Kord-Varkaneh5, Seyed Mohammad Mousavi6, Shimels Hussien Mohammed6, Ahmad Saedisomeolia7,8, Shahab Alizadeh9.   

Abstract

BACKGROUND: Inflammatory processes are involved in chronic diseases. It has been suggested that melatonin reduces inflammation by its radical scavenging properties; however, the results of the previous studies are inconclusive. The objective of the present meta-analysis is to determine the direction and magnitude of melatonin supplementation effect on inflammatory biomarkers.
METHODS: Databases including PubMed, Scopus, Cochran Library, Embase, and Google Scholar were searched up to April 2019. Meta-analysis was performed using random-effect model. Subgroup analysis, sensitivity analysis, and meta-regression were also carried out.
RESULTS: Thirteen eligible studies with 22 datasets with total sample size of 749 participants were included in the meta-analysis. Melatonin supplementation significantly decreased TNF-α and IL-6 levels [(WMD = - 2.24 pg/ml; 95% CI - 3.45, - 1.03; P < 0.001; I2 = 96.7%, Pheterogeneity < 0.001) and (WMD = - 30.25 pg/ml; 95% CI - 41.45, - 19.06; P < 0.001, I2 = 99.0%; Pheterogeneity < 0.001)], respectively. The effect of melatonin on CRP levels was marginal (WMD = - 0.45 mg/L; 95% CI - 0.94, 0.03; P = 0.06; I2 = 96.6%, Pheterogeneity < 0.001).
CONCLUSION: The results of the present meta-analysis support that melatonin supplementation could be effective on ameliorating of inflammatory mediators.

Entities:  

Keywords:  C-Reactive protein; Inflammation; Interleukin-6; Melatonin; Meta-analysis; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2019        PMID: 31679041     DOI: 10.1007/s00394-019-02123-0

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  19 in total

1.  Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatonin.

Authors:  P Lissoni; S Pittalis; F Rovelli; M Roselli; A Ardizzoia
Journal:  Oncol Rep       Date:  1996-05       Impact factor: 3.906

2.  A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women.

Authors:  N Mesri Alamdari; R Mahdavi; N Roshanravan; N Lotfi Yaghin; A R Ostadrahimi; E Faramarzi
Journal:  Horm Metab Res       Date:  2014-08-15       Impact factor: 2.936

3.  Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.

Authors:  Fariba Raygan; Vahidreza Ostadmohammadi; Fereshteh Bahmani; Russel J Reiter; Zatollah Asemi
Journal:  Clin Nutr       Date:  2017-12-12       Impact factor: 7.324

4.  The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment.

Authors:  Amir Ghaderi; Hamid Reza Banafshe; Naghmeh Mirhosseini; Maryam Motmaen; Fatemeh Mehrzad; Fereshteh Bahmani; Esmat Aghadavod; Mohammad Ali Mansournia; Russel J Reiter; Mohammad-Amin Karimi; Zatollah Asemi
Journal:  Addict Biol       Date:  2018-06-27       Impact factor: 4.280

Review 5.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 6.  Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity.

Authors:  D-X Tan; L C Manchester; L Fuentes-Broto; S D Paredes; R J Reiter
Journal:  Obes Rev       Date:  2011-03       Impact factor: 9.213

7.  Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.

Authors:  Sridevi Devaraj; Scott Leonard; Maret G Traber; Ishwarlal Jialal
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

8.  Global warming and obesity: a systematic review.

Authors:  R An; M Ji; S Zhang
Journal:  Obes Rev       Date:  2017-10-04       Impact factor: 9.213

9.  The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery.

Authors:  Shaghayegh Haghjooy Javanmard; Kiyan Heshmat-Ghahdarijani; Mohsen Mirmohammad-Sadeghi; Sayed Ali Sonbolestan; Amin Ziayi
Journal:  Adv Biomed Res       Date:  2016-11-28

10.  The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.

Authors:  Hassan Pakravan; Mehdi Ahmadian; Ali Fani; Davood Aghaee; Sareh Brumanad; Bahram Pakzad
Journal:  Adv Biomed Res       Date:  2017-04-17
View more
  19 in total

Review 1.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

Review 2.  Clinical efficacy of melatonin as adjunctive therapy to non-surgical treatment of periodontitis: a systematic review and meta-analysis.

Authors:  Ru-Yue Liu; Lin Li; Zhong-Ti Zhang; Ting Wu; Shuang Lin; Xu-Tong Zhang
Journal:  Inflammopharmacology       Date:  2022-03-15       Impact factor: 4.473

3.  Reply to M Amiri et al.

Authors:  Mehran Rahimlou; Nasrin Banaie Jahromi; Nazila Hasanyani; Amirhossein Ramezani Ahmadi
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

Review 4.  Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.

Authors:  Virna Margarita Martín Giménez; Felipe Inserra; Carlos D Tajer; Javier Mariani; León Ferder; Russel J Reiter; Walter Manucha
Journal:  Life Sci       Date:  2020-05-15       Impact factor: 5.037

Review 5.  Is Melatonin the Cornucopia of the 21st Century?

Authors:  Nadia Ferlazzo; Giulia Andolina; Attilio Cannata; Maria Giovanna Costanzo; Valentina Rizzo; Monica Currò; Riccardo Ientile; Daniela Caccamo
Journal:  Antioxidants (Basel)       Date:  2020-11-05

Review 6.  Treatment and research lines for the patient with COVID-19. What do we have and where are we going?

Authors:  Carolina Gotera
Journal:  Int Braz J Urol       Date:  2020-07       Impact factor: 1.541

7.  Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study.

Authors:  Jichen Zhang; Jiancan Lu; Hongling Zhu; Xinglu Zhou; Xijuan Wei; Mingjun Gu
Journal:  Int J Endocrinol       Date:  2021-04-28       Impact factor: 3.257

8.  Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc.

Authors:  Salvatore Corrao; Raffaella Mallaci Bocchio; Marika Lo Monaco; Giuseppe Natoli; Attilio Cavezzi; Emidio Troiani; Christiano Argano
Journal:  Nutrients       Date:  2021-04-12       Impact factor: 5.717

9.  Sleep and Immunity.

Authors:  M G Poluektov
Journal:  Neurosci Behav Physiol       Date:  2021-06-23

10.  Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease?

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  J Med Virol       Date:  2020-06-24       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.